Skip to main content
OpenTrials
Completed

NCT Number: NCT02021838

Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative

In collaboration with the National Institute of Justice (NIJ) and the Office for Violence Against Women (OVW) the Yale University team will evaluate the implementation process and impact of the U.S. Department of Justice's Domestic Violence Homicide Prevention Demonstration Initiative. This evaluation seeks to draw critical findings and potential lessons from the combined experience of the sites including: 1) how the models work in different communities; 2) the barriers and facilitators to implementing the models; and 3) outcomes of the model delivery. The evaluation team will also disseminate the findings with the goal of informing replication.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Yale University

New Haven, Connecticut, 06511, United States

About this study

Process Evaluation: The process evaluation will assess: 1) the training and technical assistance provided to sites; 2) the implementation of the models in the communities; and 3) characteristics of the service delivery systems.

Technical Assistance Providers will document the training and technical assistance (TTA) they provide to the sites.

Sites will be asked to identify key stakeholders to participate in interviews before the implementation begins and then two additional times during the demonstration phase. Key informant interviews will assess: recipient's perception of the training and technical assistance; model fidelity; model implementation (including model penetration, barriers and facilitators to implementation); and, perceptions of model impact. In addition to key informant interviews administrative data will be gathered to assess aspects of model implementation and systematic observations of law enforcement initiated screens will be conducted by a member of the evaluation team who will join patrol officers for "ride-alongs".

Impact Evaluation: The impact evaluation will assess changes in: 1) collaboration among service sectors; 2) supervision and sanctions for offenders; 3) recidivism and re-victimization; 4) victim reported feelings of safety; 5) utilization of resources; and 6) nature of safety planning.

System Collaboration will be assessed through a web-based survey completed at three time points by key stakeholders representing all potential partners in the community. Social network analysis will provide a visual depiction of how the network changes over time.

Victim Interviews will be conducted to determine the impact of involvement in the model program on their safety and wellbeing. Victims will be interviewed at three time points and will be asked about: prior and recent contact with law enforcement, domestic violence service providers or other providers; awareness of resources to address IPV; their safety and fear of their partner; coping strategies utilized; social support; financial resources; willingness to utilize criminal justice system and domestic violence service providers; both their and offenders behavior, beliefs and attitudes; self-reported mental health and substance abuse; their report of offenders substance abuse; and demographic information.

Administrative Data will be utilized to examine the breadth of the model implementation; the impact of the model programs on criminal justice processes; and whether there is a connection between the extent of post-risk assessment sanctions and services and the pattern of newly recorded incidents between the victim and offender. The evaluation will compare processing and outcomes across cases that are in many ways similar except that some cases were determined to be high risk and a risk assessment was completed and others where a risk assessment was not conducted. To facilitate these comparisons, the evaluation team will build a comprehensive database that will depict the "life-history" of each victim and offender dyad.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

The demonstration sites are:

California North Carolina Ohio Illinois Michigan Tennessee

Treatment and study plan

Lethality Assessment Program

Other

Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services.

Other names: LAP

Domestic Violence High Risk Team

Other

Law enforcement officers conduct risk screen of domestic violence victims, if high risk victims are referred to domestic violence services and a team who monitors the clinical and criminal justice progress.

Other names: HRT

Primary outcomes

  1. Decreased frequency of re-assault

    Time frame: up to 3 years

    Decrease in harassment, assault, injury, homicide/mortality

Secondary outcomes

  1. Increased collaboration between network partners

    Time frame: up to 3 years

    Increased information sharing, case planning, coordinated response

  2. Increased awareness of and utilization of resources for victims

    Time frame: Up to 3 years

    Increased awareness of and utilization of community resources

  3. Increased safety planning

    Time frame: Up to 3 years

    Increased safety planning at the time of police intervention

  4. Increased victim reported safety

    Time frame: Up to 3 years

    Victim reported changes in perceptions of safety

  5. Increased sanctions for offender

    Time frame: Up to 3 years

    Sanctions such as pre-trial containment, cases to trial, adjudications, containment post-adjudication

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Michigan State University

Registry information

Official study title

Evaluation of the Domestic Violence Homicide Prevention Initiative

Acronym: DVHPDI

Important dates

Study start
2014
Primary completion
2020
Study completion
2020
First posted
Dec 27, 2013
Registry last updated
Mar 24, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.